Blood | American Society of Hematology

Skip Nav Destination

Current Issue

Volume 145,

Issue 17,

April 24 2025

View This Issue

Issue Highlights

Systemic mastocytosis with an associated hematological neoplasm
How I Treat Series: myeloproliferative neoplasms
Salvage autologous transplant in relapsed myeloma
Memory CART30 for refractory CD30 lymphoma
Inhibiting DOT1L and EZH2 in DLBCL
Determinants of response to DDAVP

Latest in Blood

Free Articles

Nonleukemic T/B mixed phenotype acute leukemia with PHF6 and NOTCH1 mutations

Oscar Silva; Allison Shaw

https://doi.org/10.1182/blood.2021012538

View All Free Articles

Plenary Papers

Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study

Ada Antypiuk; S. Zebulon Vance; Richa Sharma; Sara Passos; Michela Asperti; Shobana Navaneethabalakrishan; Franz Dürrenberger; Vania Manolova; Francesca Vinchi

https://doi.org/10.1182/blood.2024026135

View All Plenary Papers

First Edition

Coordinated regulation of self-renewal and cell cycle during human lympho-myeloid lineage restriction

Fangwu Wang; Laura Gonzalez; Qiuyu Lian; Colin A Hammond; Yasmine Y.M. Lau; Benjamin D. Simons; Martin Hirst; Connie J Eaves

https://doi.org/10.1182/blood.2024026936

View All First Edition Articles

Clinical Trials and Observations

Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study

Ioannis Mantzaris; Mendel Goldfinger; Matan Uriel; Aditi Shastri; Nishi Shah; Kira Gritsman; Noah S. Kornblum; Lauren Shapiro; Roberto Alejandro Sica; Anne Munoz; Nicole Chambers; Aradhika Dhawan; Jhannine Alyssa Verceles; Karen Fehn; Balda Tirone; Lamisha Shah; Shaunmonique Clark; Chenxin Zhang; Mimi Kim; Dennis L. Cooper; Amit Verma; Marina Konopleva; Eric J. Feldman

https://doi.org/10.1182/blood.2024026700

View All Clinical Trials and Observations

Advertisement intended for health care professionals

2024 Blood Cover Art Contest Winner
Year in review: Blood's ten most read articles published in 2024

170,000 citations
earned in 2023

Acknowledgement of Reviewers for 2024

Issue Highlights

170,000 citations
earned in 2023

Featured Content

The decline of transplant for relapsed myeloma; DDAVP response in bleeding disorders; dual DOT1L/EZH2 targeting in DLBCL

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B-cell lymphoma

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma

How I Treat Series: Myeloproliferative Neoplasms

ASH Publications

American Society of Hematology

Issue Highlights

170,000 citations earned in 2023

Featured Content

The decline of transplant for relapsed myeloma; DDAVP response in bleeding disorders; dual DOT1L/EZH2 targeting in DLBCL

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B-cell lymphoma

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma

How I Treat Series: Myeloproliferative Neoplasms

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

170,000 citations
earned in 2023